Hepatitis D–how is the fight against this foe going?

Alessandro Loglio; Simone Segato; Pietro Lampertico

doi:10.1080/17512433.2019.1577135

Hepatitis D–how is the fight against this foe going?

Alessandro Loglio, Simone Segato, Pietro Lampertico

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	169-171
Number of pages	3
Journal	Expert Review of Clinical Pharmacology
Volume	12
Issue number	3
DOIs	https://doi.org/10.1080/17512433.2019.1577135
Publication status	Published - Mar 4 2019

Keywords

HDV
Interferon Lambda
Lonafarnib
Myrcludex-B
Nucleic Acid Polymers
Pegylated Interferon alpha

ASJC Scopus subject areas

Pharmacology, Toxicology and Pharmaceutics(all)
Pharmacology (medical)

Access to Document

10.1080/17512433.2019.1577135

Cite this

@article{3a4605996207479da1c9d40d9d4824cb,

title = "Hepatitis D–how is the fight against this foe going?",

keywords = "HDV, Interferon Lambda, Lonafarnib, Myrcludex-B, Nucleic Acid Polymers, Pegylated Interferon alpha",

author = "Alessandro Loglio and Simone Segato and Pietro Lampertico",

year = "2019",

month = mar,

day = "4",

doi = "10.1080/17512433.2019.1577135",

language = "English",

volume = "12",

pages = "169--171",

journal = "Expert Review of Clinical Pharmacology",

issn = "1751-2433",